NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-241983 |
|---|---|
| Form Type | 4 |
| Filing Date | May 27, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
195,000
Total Value
$2,974,350.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | May 26, 2026 | Exercise/Conversion | 60,000 | $10.00 | $600,000.00 | 84,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | May 26, 2026 | Exercise/Conversion | 5,000 | $10.90 | $54,500.00 | 89,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | May 26, 2026 | Sale | 65,000 | $35.69 | $2,319,850.00 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | May 26, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 80,015 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | May 26, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 68,134 | Direct | โ | View Details |